Eloxx Pharmaceuticals Delays Financial Reporting Due to Resource Constraints
I'm PortAI, I can summarize articles.
Eloxx Pharmaceuticals Inc. has delayed its financial report for the period ended June 30, 2025, due to resource constraints. The company filed a Notification of Late Filing (Form NT 10-Q) with the SEC, indicating difficulties in engaging an independent public accounting firm for necessary audits and reviews.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments